Literature DB >> 29523271

Association of gene polymorphisms of aldosterone synthase and angiotensin converting enzyme in pre-eclamptic South African Black women.

Myint Aung1, Tadashi Konoshita2, Jagadissan Moodley3, Prem Gathiram4.   

Abstract

INTRODUCTION: The exact cause of preeclampsia (PE) remains elusive. Recently, many researchers have focused on the role of genetic variations in pathogenesis of PE. The renin-angiotensin-aldosterone system is affected in the pathogenesis of PE.
OBJECTIVES: To determine association of gene polymorphisms of aldosterone synthase (CYP11B2) and angiotensin converting enzyme (ACE) in PE and normotensive South African Black women.
METHODS: A group of 603 South African Black pregnant women, 246 normotensive and 357 with PE, was recruited. Purified DNA was extracted from venous blood. The distribution and frequencies of gene polymorphisms of CYP11B2 (C-344T) and ACE deletion/insertion (D/I) were determined by real time polymerase chain reaction.
RESULTS: As the main outcome measure, the risk of C allele for PE was 1.28 (95%CI: 0.94-1.74; p = .1) for all allele comparisons. Thus no significant association with development of PE was observed for the CYP11B2 variants. However, post analysis of the distribution of TT genotypes of CYP11B2 were higher in the HIV uninfected normotensive than in the HIV uninfected PE group (OR: 0.47, 95%CI: 0.27-0.79, p = .0027). The C alleles of late-onset PE and HIV uninfected PE were higher than all normotensive and HIV uninfected normotensive (OR: 1.47, 95%CI: 1.02-2.10, p = .03 and OR: 1.77, 95%CI: 1.13-2.81, p = .0094 respectively). The CT genotype of CYP11B2 was statistically significant between normotensive and PE in HIV uninfected groups (OR: 2.24, 95%CI: 1.28-3.98, p = .0026). There was no significant difference in frequencies of D/I for ACE gene in PE.
Copyright © 2017 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACEgene; CYP11B2; Gene polymorphism; Preeclampsia

Mesh:

Substances:

Year:  2017        PMID: 29523271     DOI: 10.1016/j.preghy.2017.12.004

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  6 in total

Review 1.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

2.  Role of ACE I/D polymorphism in pathological assessment of preeclampsia in Pakistan.

Authors:  Ghazala Shaheen; Sabahat Sajid; Suhail Razak; Saeeda Batool Mazhar; Tayyaba Afsar; Ali Almajwal; Iftikhar Alam; Sarwat Jahan
Journal:  Mol Genet Genomic Med       Date:  2019-06-07       Impact factor: 2.183

3.  Correlation between CYP11B2 polymorphism and the risk of preeclampsia.

Authors:  Yan Wang; Minhua Zhou; Xun Deng; Yanjiao Ma; Deqi Jiang
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

4.  Three polymorphisms of renin-angiotensin system and preeclampsia risk.

Authors:  Chen Wang; Xiao Zhou; Huai Liu; Shuhui Huang
Journal:  J Assist Reprod Genet       Date:  2020-11-23       Impact factor: 3.412

5.  Genotypic analysis of the female BPH/5 mouse, a model of superimposed preeclampsia.

Authors:  Jenny L Sones; Christina C Yarborough; Valerie O'Besso; Alexander Lemenze; Nataki C Douglas
Journal:  PLoS One       Date:  2021-07-16       Impact factor: 3.240

6.  Association of -344C/T polymorphism in the aldosterone synthase (CYP11B2) gene with cardiac and cerebrovascular events in Chinese patients with hypertension.

Authors:  Lili Wang; Zhi Zhang; Dongxia Liu; Kexin Yuan; Guohua Zhu; Xiaoyong Qi
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.